Accepted at 8:59 p.m. Jan, 05, 2024 by Ahmed7
Author: barrwei99
Co-authors: Ahmed7
Related Note: 1474666075079
Rationale for change

September 2023: FDA no longer recommends phenylephrine as a nasal decongestant due to data showing lack of efficacy.
Source: Society Guidelines - https://www.fda.gov/drugs/drug-safety-and-availability/fda-clarifies-results-recent-advisory-committee-meeting-oral-phenylephrine

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#FirstAid::16_Respiratory::05_Pharm::03_Pseudoephedrine_phenylephrine #AK_Step1_v12::#AMBOSS::gPaFVk #AK_Step1_v12::#B&B::16_Neuro::04_Autonomic_Nervous_System::05_Adrenergic_Drugs_II::Extra #AK_Step1_v12::#AMBOSS::hlac9k #AK_Step1_v12::#Textbooks::#Golan_Pharmacology::11_Adrenergic_Pharmacology #AK_Step2_v12::#SketchyFM::02_Chronic_Diseases::01_Cardiovascular::02_Hypertension:_Ambulatory_Concerns #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Physeo::09_Pharm::08_Respiratory::04_Pseudoephedrine,_Phenylephrine #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#NBME::16 #AK_Step1_v12::#Pixorize::03_Pharmacology::04_Sympathomimetics_&_Sympatholytics::08_Phenylephrine_and_Pseudoephedrine #AK_Step1_v12::#AMBOSS #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::13_Sympatholytics_(alpha2-agonists)::*Sympatholytics_(a2-Agonists)::Phenylephrine #PANCE::EENT::nose_and_sinus #AK_Step1_v12::#Physeo::11_Pathology::01_Cardiac_Pathology::02_Hypertension #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::13_Sympatholytics_(alpha2-agonists)::*Sympatholytics_(a2-Agonists)::Pseudoephedrine #AK_Step1_v12::#SketchyPharm::04_Smooth_Muscle::FA-pulm #AK_Other::Only_Step_1 #AK_Step1_v12::#NBME::29 #AK_Step2_v12::#SketchyIM::01_Cardiology::06_Blood_Pressure::01_Hypertension_SOA #AK_Step1_v12::#Pixorize::03_Pharmacology::23_Sympathomimetics_&_Sympatholytics_(New)::07_Phenylephrine #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#B&B::06_Cardio::08_Hypertension::02_Secondary_Hypertension #AK_Step1_v12::#B&B::16_Neuro::04_Autonomic_Nervous_System::04_Adrenergic_Drugs_I::Extra #AK_Step1_v12::^Systems::Respiratory::Pharmacology #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Cardiology::Hypertension #AK_Step1_v12::#SketchyPharm::01_Autonomic_Drugs::02_Sympathetic::01_Sympathomimetics #AK_Step1_v12::#DirtyMedicine::15_Pulmonology/Respiratory::05_Respiratory_Pharmacology